Cyclin-dependent kinase inhibitor 1A mRNA 3'-untranslated region (CDKN1A mRNA 3'-UTR)

The CDKN1A mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the transcript encoding the p21 protein, a potent cyclin-dependent kinase inhibitor that mediates cell cycle arrest, DNA repair, and senescence (MDPI, 2023). This region serves as a hub for post-transcriptional control, containing multiple binding sites for microRNAs (miRNAs) and RNA-binding proteins (RBPs) that collectively determine the stability and translation efficiency of the CDKN1A message (Nature Structural & Molecular Biology, 2009; NIH, 2022). In many malignancies, oncogenic miRNAs such as the miR-106b~25 and miR-17~92 clusters target the 3'-UTR to suppress p21 expression, thereby promoting uncontrolled cell proliferation and evasion of apoptosis (Molecular and Cellular Biology, 2008). Conversely, RBPs like HuR (ELAVL1) can bind to AU-rich elements within the 3'-UTR to stabilize the mRNA and enhance p21 production in response to cellular stress (NIH, 2011). Therapeutic strategies targeting this region include antisense oligonucleotides (ASOs) and small molecules designed to disrupt inhibitory miRNA binding or modulate RBP interactions to restore p21's tumor-suppressive functions (Selleckchem, 2025). However, the dual role of p21—acting as a tumor suppressor in the nucleus but potentially promoting chemoresistance when localized in the cytoplasm—presents a significant challenge for therapeutic intervention (NIH, 2025).

Other names

p21 mRNA 3'-UTRWAF1 mRNA 3'-UTRCIP1 mRNA 3'-UTRCDKN1A 3'-untranslated regionp21 3'-UTR

Modulation of p21 expression levels by interfering with or mimicking the binding of regulatory factors, such as microRNAs and RNA-binding proteins, to the 3'-UTR sequence, thereby affecting mRNA stability and translation efficiency.